Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...
In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...
Assessing Patient-Reported Financial, Social, and Time Toxicity in Early-Phase Cancer Clinical Trials in Australia Through a Prospective Multicenter Nonrandomized Cohort Study We conducted a ...
Accordingly, it is not surprising that a leading institution such as Johns Hopkins Medicine is at the forefront of this trend. John Hopkins University was an early participant in the clinical ...
Zydus Lifesciences on Wednesday said it has launched a biosimilar for the treatment of osteoporosis and the prevention of skeletal complications in cancer patients. The company has launched ...
Verywell Health on MSN
Timing to Castration-Resistant Prostate Cancer (CRPC)
Medically reviewed by Matthew Wosnitzer, MD Key Takeaways Most prostate cancers become castration-resistant in about two to ...
Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...
Source: Getty Images Drs Uzzo, Chung, and Croll of Fox Chase Cancer Center at Temple University Health share their top picks from SUO 2025. Progress in the management of urologic malignancies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback